Showing results (51-60 of 71) with videos related to
Sort By:
Pageof 8
Breast Cancer Research : BCR|September 30, 2020
Mammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 yearsAdam R Brentnall, Ruth Warren, Elaine F Harkness, et al.JAMA Oncology|January 19, 2018
Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk PredictionElke M van Veen, Adam R Brentnall, Helen Byers, et al.Radiology|July 27, 2010
Mammographic features of breast cancers at single reading with computer-aided detection and at double reading in a large multicenter prospective trial of computer-aided detection: CADET IIJonathan J James, Fiona J Gilbert, Matthew G Wallis, et al.Cancer Prevention Research (Philadelphia, Pa.)|July 23, 2014
Breast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemopreventionD Gareth Evans, Adam R Brentnall, Michelle Harvie, et al.International Journal of Cancer|June 29, 2019
A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic densityAdam R Brentnall, Elke M van Veen, Elaine F Harkness, et al.The Journal of Pathology|February 23, 2011
Clinical and functional significance of α9β1 integrin expression in breast cancer: a novel cell-surface marker of the basal phenotype that promotes tumour cell invasionMichael D Allen, Reza Vaziri, Michael Green, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 4, 2017
RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast CancerAnthony Howell, Linda Ashcroft, Lesley Fallowfield, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2025
LATE-STAGE OUTCOMES AS SURROGATES FOR MORTALITY IN CANCER SCREENING TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSISMatejka Rebolj, Adam R Brentnall, Julia Geppert, et al.British Journal of Cancer|July 8, 2025
HPValidate-human papillomavirus testing with DNA and mRNA assays on self-collected samples in cervical screening: comparison of test characteristics on three self-sampling devicesChristopher S Mathews, Alexandra Sargent, Kate Cuschieri, et al.International Journal of Cancer|November 10, 2018
Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trialDarrel A Cook, Mel Krajden, Adam R Brentnall, et al.Pageof 8